GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Staar Surgical Co (FRA:SR3) » Definitions » Price-to-Owner-Earnings

Staar Surgical Co (FRA:SR3) Price-to-Owner-Earnings : 734.60 (As of Jun. 06, 2024)


View and export this data going back to . Start your Free Trial

What is Staar Surgical Co Price-to-Owner-Earnings?

As of today (2024-06-06), Staar Surgical Co's share price is €36.73. Staar Surgical Co's Owner Earnings per Share (TTM) ended in Mar. 2024 was €0.05. It's Price-to-Owner-Earnings for today is 734.60.


The historical rank and industry rank for Staar Surgical Co's Price-to-Owner-Earnings or its related term are showing as below:

FRA:SR3' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 124.33   Med: 416.66   Max: 15666.67
Current: 780.96

During the past 13 years, the highest Price-to-Owner-Earnings of Staar Surgical Co was 15666.67. The lowest was 124.33. And the median was 416.66.


FRA:SR3's Price-to-Owner-Earnings is ranked worse than
97.89% of 285 companies
in the Medical Devices & Instruments industry
Industry Median: 32.03 vs FRA:SR3: 780.96

As of today (2024-06-06), Staar Surgical Co's share price is €36.73. Staar Surgical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was €0.29. Therefore, Staar Surgical Co's PE Ratio for today is 127.53.

As of today (2024-06-06), Staar Surgical Co's share price is €36.73. Staar Surgical Co's EPS without NRI for the trailing twelve months (TTM) ended in was €0.55. Therefore, Staar Surgical Co's PE Ratio without NRI for today is 67.39.

During the past 13 years, Staar Surgical Co's highest PE Ratio without NRI was 1153.70. The lowest was 41.03. And the median was 156.90.


Staar Surgical Co Price-to-Owner-Earnings Historical Data

The historical data trend for Staar Surgical Co's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Staar Surgical Co Price-to-Owner-Earnings Chart

Staar Surgical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 171.58 6,250.00 198.83 342.15 -

Staar Surgical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 570.80 - - - 692.00

Competitive Comparison of Staar Surgical Co's Price-to-Owner-Earnings

For the Medical Instruments & Supplies subindustry, Staar Surgical Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Staar Surgical Co's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Staar Surgical Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Staar Surgical Co's Price-to-Owner-Earnings falls into.



Staar Surgical Co Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Staar Surgical Co's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=36.73/0.05
=734.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Staar Surgical Co  (FRA:SR3) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Staar Surgical Co Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Staar Surgical Co's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Staar Surgical Co (FRA:SR3) Business Description

Traded in Other Exchanges
Address
25651 Atlantic Ocean Drive, Lake Forest, CA, USA, 92630
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also make lenses which are used in surgery that treats cataracts. The company offers products are ICLs used in refractive surgery and IOLs used in cataract surgery. The company generated sales are from the ophthalmic surgical product segment.

Staar Surgical Co (FRA:SR3) Headlines

No Headlines